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Summary
To test the hypothesis that fibrotic burden in remote
myocardium quantified by CMR during early period of
infarct healing is a strong determinant of the cardiac
remodeling outcome.
Background
After acute myocardial infarction (AMI), co-existing
myocardial stunning, ischemia, and architectural altera-
tion may yield variable patterns of ventricular remodel-
ing with potential long-term prognostic implications.
We hypothesize that CMR quantification of fibrotic con-
tent, based on R1 (1/T1) assessment, in non-infarct
myocardium early after infarction and during the infarct
healing phases may provide novel prediction of the final
infarct size and alteration of ventricular functions during
infarct healing.
Methods
We quantified infarct size by late gadolinium enhance-
ment (LGE), mean segmental fibrotic index (FIMeanSeg)
and total LV fibrotic burden (FITotal), ventricular func-
tion and sizes during subacute (2-4 weeks) and chronic
stages (6 months) of healing in 62 AMI patients (45
men, mean LVEF 55±8%). Infarct-healing period was
defined as the time between the subacute and the
chronic stages. For the purpose of quantifying FIMeanSeg
and FITotal, we serially quantified the ratio of myocardial
to blood pool R1 changes (from before, and up to 30
minutes after contrast injection) to measure the expan-
sion of the extracellular matrix as a marker of fibrosis.
Three parallel short-axis slices were acquired for fibrotic
quantification using a cine-IR sequence and slice-
matched LGE imaging. Myocardial segments with any
LGE were excluded from quantification of fibrotic
indices. Serum hematocrit was used to estimate the
plasma R1 from the measured blood R1.
Results
From subacute to chronic stage, FIMeanSeg in remote
myocardium increased significantly (from 0.32±0.05 to
0.35±0.07, P=0.008). Severity of increased FIMeanSeg dur-
ing the infarct-healing period was correlated to the
severity in worsening of LVEF (r=-0.27, P=0.03), trend
worsening of LVESV (r=0.24, P=0.07), and significant
worsening of RVESV (r=0.34, P=0.009). Linear regres-
sion demonstrated that FIMeanSeg was one of the stron-
gest predictors of final infarct mass (in grams) at the
chronic stage. Specifically, both FIMeanSeg at the subacute
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demonstrated strong and independent association with
the extent of the final infarct mass at the chronic stage,
incremental to infarct mass measured at the subacute
stage (P=0.004 and P=0.02, respectively, for improved
model F-value).
Conclusions
Quantification of non-infarcted fibrotic burden during
subacute stage and its change during infarct-healing
provides strong prediction of the severity of the LV and
RV post-MI remodeling and of final infarct size at 6
months.
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